Company · CIK 0001593034 · SIC 2834 — Pharmaceutical Preparations
Endo International plc · ENDP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2016 FForm 4 → | Sep 28, 6:25 pm EDT | Paul CampanelliPresident & CEO, Director | 1,981 | $22.26 | $44,097 | 202,930 | — | plan? |
| Sep 24, 2016 FForm 4 → | Sep 27, 4:03 pm EDT | Suketu UpadhyayEVP, Chief Financial Officer | 1,618 | $22.44 | $36,308 | 22,412 | — | plan? |
| Aug 16, 2016 AForm 4 → | Aug 18, 11:15 am EDT | Joseph CiaffoniPresident, U.S. Branded Pharma | 52,356 | — | — | 17,452 | — | plan? |
| Aug 11, 2016 AForm 4 → | Aug 15, 3:08 pm EDT | Suketu UpadhyayEVP, Chief Financial Officer | 105,931 | — | — | 99,005 | — | plan? |
| May 16, 2016 AForm 4 → | May 18, 4:32 pm EDT | Daniel RudioVice President, Controller | 7,078 | — | — | 10,016 | — | plan? |
| May 11, 2016 PForm 4 → | May 12, 1:08 pm EDT | Arthur J HigginsDirector | 5,000 | $13.80 | $69,000 | 50,623 | +11.0% | plan? |
| May 10, 2016 PForm 4 → | May 11, 2:26 pm EDT | Roger H KimmelDirector | 7,000 | $15.53 | $108,720 | 195,000 | +3.72% | plan? |
| May 10, 2016 PForm 4 → | May 11, 2:22 pm EDT | Arthur J HigginsDirector | 11,000 | $15.42 | $169,620 | 45,623 | +31.8% | plan? |
| May 10, 2016 PForm 4 → | May 11, 2:20 pm EDT | Paul CampanelliGroup President, Generics | 13,000 | $15.53 | $201,890 | 201,069 | +6.91% | plan? |
| May 5, 2016 SForm 4/A → | May 18, 4:28 pm EDT | Douglas S IngramDirector | 4,513 | $26.59 | $120,001 | 4,890 | −48.0% | plan? |
| May 5, 2016 AForm 4/A → | May 18, 4:28 pm EDT | Douglas S IngramDirector | 9,403 | $26.59 | $250,026 | 9,403 | — | plan? |
| May 5, 2016 AForm 4 → | May 9, 4:41 pm EDT | Douglas S IngramDirector | 9,403 | $26.59 | $250,026 | 9,403 | — | plan? amended |
| Apr 29, 2016 FForm 4 → | May 2, 4:46 pm EDT | Hemanth Jacob VarghesePres. International Pharma | 449 | $27.56 | $12,374 | 4,350 | — | plan? |
| Apr 29, 2016 FForm 4 → | May 2, 4:41 pm EDT | Matthew Joseph MalettaExec. V.P.,Chief Legal Officer | 279 | $27.56 | $7,689 | 1,624 | — | plan? |
| Mar 18, 2016 FMForm 4 → | Mar 22, 4:10 pm EDT | Rajiv De SilvaPresident & CEO, Director | 178,161 | $29.90 | $1,026,793 | 291,695 | — | plan? |
| Mar 17, 2016 PForm 4 → | Mar 17, 7:03 pm EDT | William SpenglerDirector | 1,000 | $29.20 | $29,200 | 48,835 | +2.09% | plan? |
| Mar 16, 2016 PForm 4 → | Mar 16, 1:36 pm EDT | William SpenglerDirector | 1,000 | $35.24 | $35,240 | 47,835 | +2.14% | plan? |
| Mar 14, 2016 PForm 4 → | Mar 14, 3:07 pm EDT | Roger H KimmelDirector | 1,125 | $41.94 | $47,183 | 73,362 | +1.56% | plan? |
| Mar 11, 2016 FForm 4 → | Mar 14, 5:53 pm EDT | Susan HallEVP, CSO, Global Head of R&D | 626 | $41.67 | $26,085 | 4,826 | — | plan? |
| Mar 11, 2016 MForm 4 → | Mar 14, 3:07 pm EDT | Roger H KimmelDirector | 6,764 | $41.67 | $281,856 | 72,237 | — | plan? |
| Mar 7, 2016 PForm 4 → | Mar 7, 3:58 pm EST | Matthew Joseph MalettaExec. V.P.,Chief Legal Officer | 500 | $44.48 | $22,240 | 1,000 | +100% | plan? |
| Mar 7, 2016 PForm 4 → | Mar 7, 3:57 pm EST | Rajiv De SilvaPresident & CEO, Director | 2,250 | $44.50 | $100,125 | 250,705 | +0.91% | plan? |
| Mar 2, 2016 FMForm 4 → | Mar 4, 4:45 pm EST | Brian LortiePresident Branded Pharma | 15,428 | $43.06 | $105,540 | 24,504 | — | plan? |
| Mar 2, 2016 FMForm 4 → | Mar 4, 4:43 pm EST | Rajiv De SilvaPresident & CEO, Director | 261,653 | $43.06 | $2,419,886 | 248,455 | — | plan? |
| Mar 1, 2016 SForm 4/A → | Apr 21, 5:07 pm EDT | William P MontagueDirector | 3,413 | $42.19 | $143,994 | 39,228 | −8.00% | plan? |
| Mar 1, 2016 AForm 4/A → | Apr 21, 5:07 pm EDT | William P MontagueDirector | 7,111 | — | — | 42,641 | — | plan? |
| Mar 1, 2016 SForm 4 → | Mar 3, 8:58 pm EST | William SpenglerDirector | 3,413 | $42.19 | $143,994 | 46,835 | −6.79% | plan? |
| Mar 1, 2016 AForm 4 → | Mar 3, 8:58 pm EST | William SpenglerDirector | 7,111 | — | — | 50,248 | — | plan? |
| Mar 1, 2016 SForm 4 → | Mar 3, 8:57 pm EST | Jill D. SmithDirector | 3,413 | $42.19 | $143,994 | 19,785 | −14.7% | plan? |
| Mar 1, 2016 AForm 4 → | Mar 3, 8:57 pm EST | Jill D. SmithDirector | 7,111 | — | — | 23,198 | — | plan? |
| Mar 1, 2016 AForm 4 → | Mar 3, 8:57 pm EST | William P MontagueDirector | 7,111 | — | — | 42,641 | — | plan? amended |
| Mar 1, 2016 AForm 4 → | Mar 3, 8:56 pm EST | Roger H KimmelDirector | 7,111 | — | — | 65,473 | — | plan? |
| Mar 1, 2016 SForm 4 → | Mar 3, 8:55 pm EST | Michael HyattDirector | 3,413 | $42.19 | $143,994 | 250,297 | −1.35% | plan? |
| Mar 1, 2016 AForm 4 → | Mar 3, 8:55 pm EST | Michael HyattDirector | 7,111 | — | — | 253,710 | — | plan? |
| Mar 1, 2016 SForm 4 → | Mar 3, 8:53 pm EST | Nancy J HutsonDirector | 3,413 | $42.19 | $143,994 | 36,577 | −8.53% | plan? |
| Mar 1, 2016 AForm 4 → | Mar 3, 8:53 pm EST | Nancy J HutsonDirector | 7,111 | — | — | 39,990 | — | plan? |
| Mar 1, 2016 AForm 4 → | Mar 3, 8:52 pm EST | Arthur J HigginsDirector | 11,852 | — | — | 34,623 | — | plan? |
| Mar 1, 2016 AForm 4 → | Mar 3, 8:51 pm EST | Shane CookeDirector | 7,111 | — | — | 17,290 | — | plan? |
| Feb 26, 2016 FForm 4 → | Mar 1, 6:11 pm EST | Suketu UpadhyayEVP, Chief Financial Officer | 399 | $53.80 | $21,466 | 18,292 | — | plan? |
| Feb 26, 2016 FForm 4 → | Mar 1, 6:09 pm EST | Daniel RudioVice President, Controller | 373 | $53.80 | $20,067 | 4,408 | — | plan? |
| Feb 26, 2016 FForm 4 → | Mar 1, 6:07 pm EST | Brian LortiePresident Branded Pharma | 330 | $53.80 | $17,754 | 19,169 | — | plan? |
| Feb 23, 2016 AFForm 4 → | Feb 25, 8:20 pm EST | Suketu UpadhyayEVP, Chief Financial Officer | 43,030 | $49.85 | $34,546 | 17,423 | — | plan? |
| Feb 23, 2016 AFForm 4 → | Feb 25, 8:20 pm EST | Daniel RudioVice President, Controller | 2,691 | $49.85 | $3,938 | 3,898 | — | plan? |
| Feb 23, 2016 AForm 4 → | Feb 25, 8:19 pm EST | Matthew Joseph MalettaExec. V.P.,Chief Legal Officer | 17,025 | — | — | 14,097 | — | plan? |
| Feb 23, 2016 AFForm 4 → | Feb 25, 8:19 pm EST | Brian LortiePresident Branded Pharma | 13,008 | $49.85 | $11,964 | 18,425 | — | plan? |
| Feb 23, 2016 AFForm 4 → | Feb 25, 8:17 pm EST | Susan HallEVP, CSO, Global Head of R&D | 20,235 | $49.85 | $11,914 | 3,160 | — | plan? |
| Feb 23, 2016 AForm 4 → | Feb 25, 8:15 pm EST | Rajiv De SilvaPresident & CEO, Director | 149,342 | — | — | 468,766 | — | plan? |
| Feb 23, 2016 AForm 4 → | Feb 25, 8:07 pm EST | Paul CampanelliGroup President, Generics | 35,467 | — | — | 27,189 | — | plan? |
| Feb 22, 2016 FForm 4 → | Feb 24, 5:59 pm EST | Brian LortiePresident Branded Pharma | 305 | $50.70 | $15,464 | 18,010 | — | plan? |
| Feb 22, 2016 FForm 4 → | Feb 24, 5:53 pm EST | Daniel RudioVice President, Controller | 192 | $50.70 | $9,734 | 3,793 | — | plan? |
| Dec 31, 2015 AForm 4 → | Jan 5, 2016, 4:52 pm EST | Matthew Joseph MalettaExec. V.P.,Chief Legal Officer | 9,622 | — | — | 8,422 | — | plan? |
| Nov 30, 2015 GForm 5 → | Feb 1, 2016, 5:40 pm EST | Michael HyattDirector | 10,000 | — | — | 246,599 | — | plan? |
| Nov 16, 2015 PForm 4 → | Nov 17, 10:40 am EST | Roger H KimmelDirector | 841 | $57.00 | $47,937 | 108,362 | +0.78% | plan? |
| Nov 12, 2015 PForm 4 → | Nov 12, 5:36 pm EST | Shane CookeDirector | 4,000 | $57.13 | $228,520 | 10,179 | +64.7% | plan? |
| Nov 11, 2015 MForm 4 → | Nov 12, 9:15 pm EST | Roger H KimmelDirector | 10,384 | $16.80 | $174,451 | 107,521 | — | plan? |
| Nov 11, 2015 AForm 4 → | Nov 12, 7:38 am EST | Matthew Joseph MalettaExec. V.P.,Chief Legal Officer | 500 | — | — | 7,722 | — | plan? |
| Nov 11, 2015 PForm 4 → | Nov 12, 7:38 am EST | Matthew Joseph MalettaExec. V.P.,Chief Legal Officer | 500 | $56.19 | $28,095 | 500 | — | plan? |
| Nov 11, 2015 AForm 4 → | Nov 12, 7:37 am EST | Brian LortiePresident Branded Pharma | 700 | — | — | 24,555 | — | plan? |
| Nov 11, 2015 PForm 4 → | Nov 12, 7:37 am EST | Brian LortiePresident Branded Pharma | 700 | $56.47 | $39,529 | 17,484 | +4.17% | plan? |
| Nov 11, 2015 SForm 4 → | Nov 12, 7:37 am EST | Michael HyattDirector | 8,000 | $55.48 | $443,840 | 251,599 | −3.08% | plan? |
| Nov 11, 2015 MForm 4 → | Nov 12, 7:37 am EST | Michael HyattDirector | 10,000 | $31.43 | $314,300 | 259,599 | — | plan? |
| Nov 11, 2015 AForm 4 → | Nov 12, 7:36 am EST | Susan HallEVP, CSO, Global Head of R&D | 1,000 | — | — | 13,740 | — | plan? |
| Nov 11, 2015 PForm 4 → | Nov 12, 7:36 am EST | Susan HallEVP, CSO, Global Head of R&D | 1,000 | $55.35 | $55,350 | 2,666 | +60.0% | plan? |
| Nov 11, 2015 AForm 4 → | Nov 12, 7:35 am EST | Suketu UpadhyayEVP, Chief Financial Officer | 4,450 | — | — | 51,310 | — | plan? |
| Nov 11, 2015 PForm 4 → | Nov 12, 7:35 am EST | Suketu UpadhyayEVP, Chief Financial Officer | 4,450 | $56.37 | $250,856 | 15,886 | +38.9% | plan? |
| Nov 11, 2015 AForm 4 → | Nov 12, 7:35 am EST | Paul CampanelliPresident, Par Pharmaceutical | 2,100 | — | — | 105,466 | — | plan? |
| Nov 11, 2015 PForm 4 → | Nov 12, 7:35 am EST | Paul CampanelliPresident, Par Pharmaceutical | 2,100 | $55.69 | $116,954 | 188,069 | +1.13% | plan? |
| Nov 11, 2015 PForm 4 → | Nov 12, 7:33 am EST | Rajiv De SilvaPresident & CEO, Director | 9,006 | $55.52 | $500,013 | 181,380 | +5.22% | plan? |
| Nov 5, 2015 MForm 4 → | Nov 6, 5:37 pm EST | Roger H KimmelDirector | 10,000 | $53.91 | $539,100 | 237,137 | — | plan? |
| Nov 3, 2015 AForm 4 → | Nov 5, 8:34 pm EST | Paul CampanelliGroup President, Generics | 72,632 | — | — | 103,366 | — | plan? |
| Sep 28, 2015 AForm 4 → | Sep 30, 6:29 pm EDT | Paul CampanelliGroup President, Generics | 46,101 | — | — | 30,734 | — | plan? |
| Sep 24, 2015 FForm 4 → | Sep 28, 5:23 pm EDT | Suketu UpadhyayEVP, Chief Financial Officer | 2,368 | $72.77 | $172,319 | 11,335 | — | plan? |
| Jun 16, 2015 PForm 4 → | Jun 18, 4:44 pm EDT | Arthur J HigginsDirector | 2,500 | $81.10 | $202,750 | 22,771 | +12.3% | plan? |
| Apr 7, 2015 SForm 4 → | Apr 9, 5:16 pm EDT | Caroline B ManogueExec. V.P.,Chief Legal Officer | 105,562 | $91.90 | $9,701,148 | 43,100 | −71.0% | plan? |
| Apr 7, 2015 MForm 4 → | Apr 9, 5:16 pm EDT | Caroline B ManogueExec. V.P.,Chief Legal Officer | 105,562 | $29.52 | $3,116,271 | 148,159 | — | plan? |
| Mar 11, 2015 FForm 4 → | Mar 13, 6:16 pm EDT | Susan HallEVP, CSO, Global Head of R&D | 626 | $89.44 | $55,989 | 1,666 | — | plan? |
| Mar 10, 2015 SForm 4 → | Mar 12, 5:25 pm EDT | Camille FarhatPresident, AMS, Inc. | 8,650 | $89.39 | $773,224 | 0 | −100% | plan? |
| Mar 9, 2015 SForm 4 → | Mar 11, 4:39 pm EDT | Camille FarhatPresident, AMS, Inc. | 40,438 | $87.02 | $3,518,915 | 8,650 | −82.4% | plan? |
| Mar 9, 2015 MForm 4 → | Mar 11, 4:39 pm EDT | Camille FarhatPresident, AMS, Inc. | 40,438 | $32.09 | $1,297,806 | 49,088 | — | plan? |
| Mar 5, 2015 SForm 4 → | Mar 9, 4:51 pm EDT | Caroline B ManogueExec. V.P.,Chief Legal Officer | 42,033 | $87.78 | $3,689,657 | 43,100 | −49.4% | plan? |
| Mar 5, 2015 MForm 4 → | Mar 9, 4:51 pm EDT | Caroline B ManogueExec. V.P.,Chief Legal Officer | 42,033 | $19.93 | $837,718 | 85,133 | — | plan? |
| Mar 4, 2015 SForm 4 → | Mar 6, 4:56 pm EST | Brian LortiePresident Branded Pharma | 5,800 | $85.35 | $495,030 | 16,784 | −25.7% | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 4:30 pm EST | Roger H KimmelDirector | 6,743 | — | — | 227,137 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 4:28 pm EST | William SpenglerDirector | 1,787 | — | — | 43,137 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 4:27 pm EST | Jill D. SmithDirector | 1,787 | — | — | 16,087 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 4:25 pm EST | William P MontagueDirector | 3,436 | — | — | 35,530 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 4:24 pm EST | Michael HyattDirector | 1,787 | — | — | 259,974 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 4:22 pm EST | Nancy J HutsonDirector | 3,436 | — | — | 32,879 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 4:21 pm EST | Arthur J HigginsDirector | 5,727 | — | — | 20,271 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 4:19 pm EST | John DeluccaDirector | 1,787 | — | — | 32,343 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 4:16 pm EST | Shane CookeDirector | 3,436 | — | — | 6,179 | — | plan? |
| Feb 26, 2015 FForm 4 → | Mar 2, 5:27 pm EST | Daniel RudioVice President, Controller | 332 | $85.30 | $28,321 | 3,285 | — | plan? |
| Feb 26, 2015 FForm 4 → | Mar 2, 5:26 pm EST | Caroline B ManogueExec. V.P.,Chief Legal Officer | 1,618 | $85.28 | $137,989 | 43,100 | — | plan? |
| Feb 26, 2015 FForm 4 → | Mar 2, 5:24 pm EST | Camille FarhatPresident, AMS, Inc. | 1,004 | $85.24 | $85,584 | 8,650 | — | plan? |
| Feb 26, 2015 FForm 4 → | Mar 2, 5:21 pm EST | Donald W DeGolyerChief Operating Officer,Pharma | 477 | $85.19 | $40,636 | 6,547 | — | plan? |
| Feb 26, 2015 FForm 4 → | Mar 2, 5:20 pm EST | Suketu UpadhyayEVP, Chief Financial Officer | 402 | $85.19 | $34,246 | 8,382 | — | plan? |
| Feb 24, 2015 AForm 4 → | Feb 26, 7:57 pm EST | Suketu UpadhyayEVP, Chief Financial Officer | 26,392 | — | — | 24,148 | — | plan? |
| Feb 24, 2015 AForm 4 → | Feb 26, 7:56 pm EST | Susan HallEVP, CSO, Global Head of R&D | 8,797 | — | — | 9,807 | — | plan? |
| Feb 24, 2015 AForm 4 → | Feb 26, 7:55 pm EST | Camille FarhatPresident, AMS, Inc. | 13,837 | — | — | 20,680 | — | plan? |
| Feb 24, 2015 FForm 4 → | Feb 26, 7:54 pm EST | Caroline B ManogueExec. V.P.,Chief Legal Officer | 4,132 | — | — | 41,543 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2017 AForm 4 → | Aug 11, 9:06 am EDT | Daniel RudioSVP, Controller | 15,861 | — | — | 15,861 | — | |
| Aug 10, 2017 AForm 4 → | Aug 11, 9:05 am EDT | Antonio R PeraPresident, Par Pharmaceutical | 108,901 | — | — | 108,901 | — | |
| Aug 10, 2017 AForm 4 → | Aug 11, 9:04 am EDT | Matthew Joseph MalettaEVP, Chief Legal Officer | 260,416 | — | — | 260,416 | — | |
| Aug 10, 2017 AForm 4 → | Aug 11, 9:04 am EDT | Terrance J CoughlinEVP, Chief Operating Officer | 255,681 | — | — | 255,681 | — | |
| Aug 10, 2017 AForm 4 → | Aug 11, 9:03 am EDT | Blaise ColemanEVP, Chief Financial Officer | 260,416 | — | — | 260,416 | — | |
| Aug 10, 2017 AForm 4 → | Aug 11, 9:00 am EDT | Paul CampanelliPresident, CEO, Director | 971,590 | — | — | 971,590 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 5:05 pm EST | Antonio R PeraPresident, Par Pharmaceutical | 52,154 | — | — | 52,154 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 5:04 pm EST | Matthew Joseph MalettaEVP, Chief Legal Officer | 72,278 | — | — | 72,278 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 5:00 pm EST | Terrance J CoughlinEVP, Chief Operating Officer | 127,551 | — | — | 127,551 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 4:57 pm EST | Daniel RudioSVP, Controller | 21,839 | — | — | 21,839 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 4:55 pm EST | Blaise ColemanEVP, Chief Financial Officer | 74,404 | — | — | 74,404 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 4:36 pm EST | Paul CampanelliPresident, CEO, Director | 510,204 | — | — | 510,204 | — | |
| Sep 26, 2016 AForm 4 → | Sep 28, 6:25 pm EDT | Paul CampanelliPresident & CEO, Director | 429,645 | — | — | 429,645 | — | |
| Aug 16, 2016 AForm 4 → | Aug 18, 11:15 am EDT | Joseph CiaffoniPresident, U.S. Branded Pharma | 41,972 | — | — | 41,972 | — | |
| Aug 11, 2016 AForm 4 → | Aug 15, 3:08 pm EDT | Suketu UpadhyayEVP, Chief Financial Officer | 84,900 | — | — | 84,900 | — | |
| May 16, 2016 AForm 4 → | May 18, 4:32 pm EDT | Daniel RudioVice President, Controller | 17,821 | — | — | 17,821 | — | |
| Mar 11, 2016 MForm 4 → | Mar 14, 3:07 pm EDT | Roger H KimmelDirector | 6,764 | — | — | 0 | — | |
| Feb 23, 2016 AForm 4 → | Feb 25, 8:20 pm EST | Suketu UpadhyayEVP, Chief Financial Officer | 47,599 | — | — | 47,599 | — | |
| Feb 23, 2016 AForm 4 → | Feb 25, 8:20 pm EST | Daniel RudioVice President, Controller | 4,405 | — | — | 4,405 | — | |
| Feb 23, 2016 AForm 4 → | Feb 25, 8:19 pm EST | Matthew Joseph MalettaExec. V.P.,Chief Legal Officer | 19,140 | — | — | 19,140 | — | |
| Feb 23, 2016 AForm 4 → | Feb 25, 8:19 pm EST | Brian LortiePresident Branded Pharma | 14,355 | — | — | 14,355 | — | |
| Feb 23, 2016 AForm 4 → | Feb 25, 8:17 pm EST | Susan HallEVP, CSO, Global Head of R&D | 22,481 | — | — | 22,481 | — | |
| Feb 23, 2016 AForm 4 → | Feb 25, 8:15 pm EST | Rajiv De SilvaPresident & CEO, Director | 167,897 | — | — | 167,897 | — | |
| Feb 23, 2016 AForm 4 → | Feb 25, 8:07 pm EST | Paul CampanelliGroup President, Generics | 39,875 | — | — | 39,875 | — | |
| Dec 31, 2015 AForm 4 → | Jan 5, 2016, 4:52 pm EST | Matthew Joseph MalettaExec. V.P.,Chief Legal Officer | 17,394 | — | — | 17,394 | — | |
| Nov 11, 2015 MForm 4 → | Nov 12, 9:15 pm EST | Roger H KimmelDirector | 10,384 | — | — | 0 | — | |
| Nov 11, 2015 MForm 4 → | Nov 12, 7:37 am EST | Michael HyattDirector | 10,000 | — | — | 0 | — | |
| Nov 5, 2015 MForm 4 → | Nov 6, 5:37 pm EST | Roger H KimmelDirector | 10,000 | — | — | 0 | — | |
| Sep 28, 2015 AForm 4 → | Sep 30, 6:29 pm EDT | Paul CampanelliGroup President, Generics | 56,920 | — | — | 56,920 | — | |
| Apr 7, 2015 MForm 4 → | Apr 9, 5:16 pm EDT | Caroline B ManogueExec. V.P.,Chief Legal Officer | 105,562 | — | — | 10,673 | — | |
| Mar 9, 2015 MForm 4 → | Mar 11, 4:39 pm EDT | Camille FarhatPresident, AMS, Inc. | 40,438 | — | — | 4,848 | — | |
| Mar 5, 2015 MForm 4 → | Mar 9, 4:51 pm EDT | Caroline B ManogueExec. V.P.,Chief Legal Officer | 42,033 | — | — | 0 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 7:57 pm EST | Suketu UpadhyayEVP, Chief Financial Officer | 32,470 | — | — | 32,470 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 7:56 pm EST | Susan HallEVP, CSO, Global Head of R&D | 10,823 | — | — | 10,823 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 7:55 pm EST | Camille FarhatPresident, AMS, Inc. | 17,025 | — | — | 17,025 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 7:53 pm EST | Rajiv De SilvaPresident & CEO, Director | 85,245 | — | — | 85,245 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 7:52 pm EST | Daniel RudioVice President, Controller | 2,715 | — | — | 2,715 | — |